Selera Medical develops a minimally invasive device-based treatment for heart failure, aimed at managing fluid overload and alleviating patient symptoms.
Founded
2023
Company Stage
Seed
Investors
- Y Combinator
- Fogarty Innovation
YC Batch
W24
Product Features & Capabilities
minimally invasive lymphatic offloading (MILO) procedure, leverages body's fluid management system, offloads trapped fluid, prevents fluid buildup, reduces symptoms like shortness of breath and fatigue, decreases hospitalizations, improves overall health and quality of life